Key points are not available for this paper at this time.
In 2023, 28 countries and technology private sector representatives signed the Bletchley Declaration, calling for international oversight of AI by applying a risk-based formulary. The goal is to achieve uniform global regulation. The absence of regulatory uniformity challenges companies operating across borders. This paper provides practitioners and policymakers with an overview of the EU regulatory model and a new legislative recommendation, The AI Integrative Risk-Based model for the U.S., which has not designed any regulatory framework. The AIRB provides a useful approach for conducting meaningful risk assessments to guide future U.S. regulation and ensure compliance in global markets.
Miriam F. Weismann (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: